2nd Quarter - Report

INNOVATIVE FEDERAL STRATEGIES, LLC for ADURO BIOTECH

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 2219, Department of Defense Appropriations Act, 2012, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

LobbyistCovered position, as disclosed
DAVID FREDERICK KILIAN —
AMANDA KING —
JOHN LITTLE —
LETITIA WHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2219 (112th)

Defense DEF

H.R. 1540 / S. 1253, National Defense Authorization Act, 2012, Title II, all provisions relating to infectious disease vaccines.

LobbyistCovered position, as disclosed
DAVID FREDERICK KILIAN —
AMANDA KING —
JOHN LITTLE —
LETITIA WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1253 (112th), H.R. 1540 (112th)

Government Issues GOV

Contacted Congressional offices regarding improving the process for peer review of the Department of Defense Congressionally Directed Medical Research Program.

LobbyistCovered position, as disclosed
DAVID FREDERICK KILIAN —
AMANDA KING —
JOHN LITTLE —
LETITIA WHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.